These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


106 related items for PubMed ID: 7326463

  • 1. [Histofluorescence localization of cellular sites binding steroid hormones in human breast cancers].
    Danguy A, Leclercq G, Pasteels JL, Heuson JC.
    Bull Assoc Anat (Nancy); 1981 Mar; 65(188):67-75. PubMed ID: 7326463
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Determination of steroid hormone-dependency of tumours utilizing tissue sections. Survey of histochemical techniques and their application in surgical pathology.
    De Goeij TF, Bosman FT, Berns EM.
    J Pathol; 1986 Jul; 149(3):163-72. PubMed ID: 3528443
    [Abstract] [Full Text] [Related]

  • 10. Macromolecular binding of dexamethasone as evidence for the presence of mineralocorticoid receptor in human breast cancer.
    Martin PM, Rolland PH, Raynaud JP.
    Cancer Res; 1981 Mar; 41(3):1222-6. PubMed ID: 6780185
    [No Abstract] [Full Text] [Related]

  • 11. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z, Gardi J, Nyári T, Földesi I, Hajnal-Papp R, Ormándi K, Lázár G, Thurzó L, Schally AV.
    Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
    De Maeyer L, Van Limbergen E, De Nys K, Moerman P, Pochet N, Hendrickx W, Wildiers H, Paridaens R, Smeets A, Christiaens MR, Vergote I, Leunen K, Amant F, Neven P.
    J Clin Oncol; 2008 Jan 10; 26(2):335-6; author reply 336-8. PubMed ID: 18182677
    [No Abstract] [Full Text] [Related]

  • 14. [Expression of steroid receptors and DNA synthesis in male breast cancer].
    Petroni S, Mangia A, D'Amico C, Simone G.
    Pathologica; 2003 Feb 10; 95(1):31-6. PubMed ID: 12735283
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [New concepts on hormone dependence in breast cancer].
    Levin E, Caruso SP, Actis AM, de Levin RW.
    Medicina (B Aires); 1997 Feb 10; 57(1):95-103. PubMed ID: 9435378
    [Abstract] [Full Text] [Related]

  • 17. Menopausal hormone therapy and breast cancer phenotype: does dose matter?
    Garwood ER, Kumar AS, Shim V.
    Ann Surg Oncol; 2008 Sep 10; 15(9):2526-32. PubMed ID: 18618187
    [Abstract] [Full Text] [Related]

  • 18. Oxytocin modulates estrogen receptor alpha expression and function in MCF7 human breast cancer cells.
    Cassoni P, Catalano MG, Sapino A, Marrocco T, Fazzari A, Bussolati G, Fortunati N.
    Int J Oncol; 2002 Aug 10; 21(2):375-8. PubMed ID: 12118334
    [Abstract] [Full Text] [Related]

  • 19. Steroid receptors and their role in the biology and control of breast cancer growth.
    Cordera F, Jordan VC.
    Semin Oncol; 2006 Dec 10; 33(6):631-41. PubMed ID: 17145341
    [Abstract] [Full Text] [Related]

  • 20. Cellular estrogen and progesterone receptors in mammary carcinoma.
    Lee SH.
    Am J Clin Pathol; 1980 Mar 10; 73(3):323-9. PubMed ID: 7361711
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.